Definitive Healthcare CORP 10-Q quarterly reports

Definitive Healthcare Corp. filed its Q2 2026 10-Q, revealing a year-over-year revenue decrease, a substantial goodwill impairment charge, and ongoing challenges with Nasdaq's minimum bid price requirement.

Definitive Healthcare Corp. reported a decrease in revenue for the first quarter of 2026, citing sales execution challenges and macroeconomic headwinds, while also recording a significant goodwill impairment charge.

Definitive Healthcare Corp. reported a 4% revenue decline in Q3 2025 and a 5% decline for the nine months, attributing the downturn to macroeconomic pressures and sales execution challenges, despite a reduced net loss.

Definitive Healthcare Corp. reported a net loss for Q2 2025, with revenue declining due to sales execution challenges and macroeconomic headwinds, despite a significantly lower goodwill impairment charge compared to the prior year.

Definitive Healthcare Corp. reported a net loss of $155.1 million for Q1 2025, primarily due to a goodwill impairment charge and a decrease in revenue.

Definitive Healthcare Corp. reported its Q3 2024 results, which included a substantial goodwill impairment charge and a slight decrease in revenue compared to the same period last year.

Definitive Healthcare Corp. reported its second quarter 2024 results, which were significantly impacted by a goodwill impairment charge and restructuring efforts, despite a slight increase in revenue.

Definitive Healthcare Corp. announced its first quarter 2024 results, navigating a restructuring plan and challenging macroeconomic conditions.